Unilever Acquires Grüns: What This Bet on Celebrity Greens Supplements Signals
When a company like Unilever — $60B in annual revenue, Dove, Lipton, Magnum in its portfolio — acquires a greens gummy brand co-founded with a rapper, that's a market signal worth reading carefully.
The Unilever acquisition of Grüns is official. And it says something important about where the supplement industry is heading.
Key Takeaways
- Unilever acquires Grüns, the greens gummy supplement brand co-founded with Drake
- Fits Unilever's health and wellbeing portfolio strategy (Liquid IV, Nutrafol)
- Grüns disrupted greens supplements by replacing powder format with accessible gummies
- Strong signal: Big FMCG is fully validating premium functional supplements at scale
- Celebrity-backed supplement brands now attract significant acquisition premiums from legacy CPGs
Who Grüns Is and Why Unilever Wants It
Grüns was founded by Daniel Freed with Drake as co-founder and public face. The brand took a clear position from day one: make greens supplements accessible to a mainstream audience by ditching the powder format for gummies. Same format-democratization strategy as Create Wellness with creatine — different category, same logic.
The difference from other celebrity-backed brands: Grüns built a serious product foundation before leveraging Drake's image. The formula is substantive — vitamins, minerals, plant extracts — and the gummy format solved the core problem with greens powders: taste and daily use friction.
Unilever isn't buying an image. It's buying distribution, a customer base, and a format that's proven it can reach a different audience than traditional supplement users.
Unilever's Wellness Play: A Strategy Accelerating
This acquisition isn't isolated in Unilever's strategy. The group acquired Liquid IV (electrolyte hydration) in 2020, Nutrafol (hair health supplements) in 2022. The direction is clear: Unilever is building a portfolio in premium functional supplements, targeting high-growth categories where the science is solid enough to justify a pricing premium.
Greens, creatine, electrolytes, collagen, hair — these are the five categories concentrating most supplement market growth in 2024-2026. Unilever is now positioned in three of them.
What This Means for the Supplement Market
When FMCG giants acquire premium supplement brands, several things happen simultaneously in the market.
Category validation. Unilever doesn't bet on niches — the group targets categories with mass market potential. Their choice of greens gummies confirms the category is judged mature enough for mainstream distribution.
Rising acquisition premiums. Every FMCG supplement acquisition recalibrates valuation multiples for other brands in the same space. Founders and investors in the wellness segment will reference this transaction in upcoming funding rounds and M&A conversations.
Pressure on independent brands. With Unilever's distribution power behind Grüns, independent greens brands will see their market conditions shift. Shelf space competition in retail and e-commerce visibility will intensify.
What Independent Brands Can Take From This
The Grüns acquisition confirms a dynamic the industry has watched since 2020: supplement brands that succeed on both formula AND format — and that build an audience before seeking an exit — are the most attractive to strategic acquirers. Danone's acquisition of Huel and Herbalife's purchase of Bioniq earlier this year follow the same consolidation logic.
It wasn't the Drake association that convinced Unilever. It was the demonstration that a different format could accelerate adoption of an entire category. That's the real strategic value of Grüns — and the lesson brands in build phase can take from it.